{
  "title": "Vivera Pharmaceuticals, Inc., EFT Global Holdings, Inc. d/b/a Sentar Pharmaceuticals, and Paul P. Edalat",
  "link": "https://www.sec.gov/litigation/litreleases/2022/lr25538.htm",
  "description": "SEC Charges Vivera Pharmaceuticals and Its CEO with Offering Fraud",
  "guid": "LR-25538",
  "pubDate": "Fri, 30 Sep 2022 11:57:59 EDT"
}